• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS Back to Search Results
Catalog Number 07C18-41
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, architect (b)(4), that has a similar product distributed in the us, (b)(4).
 
Event Description
The customer observed a (b)(6) anti-hbs result for one patient on the architect i2000sr analyzer.The following data was provided for a (b)(6) cancer patient: initial 53 miu/ml, repeated on another method as negative.There was no impact to patient management reported.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling, review of field data and specificity testing.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.No return patient sample was available.A significant value decrease was observed during antigen addition testing indicating possible interference in the specimen and it is possible that the anti-hbs result of 53miu/ml is a true positive result.Clinical specificity testing of negative panel replicates was performed using in-house retained kits stored at the recommended storage condition.Specificity testing met all specifications.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key9569041
MDR Text Key198750697
Report Number3008344661-2020-00003
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2020
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/06/2020
Device Catalogue Number07C18-41
Device Lot Number02262FN00
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LN 03M74-01 SN (B)(6) ; LN 03M74-01 SN (B)(6)
Patient Age58 YR
-
-